Efficacy and safety of BMS-986195 following oral administration in healthy participants.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2017
At a glance
- Drugs BMS 986195 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 19 Dec 2017 New trial record
- 08 Nov 2017 Results presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting.